{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T19:26:41Z","timestamp":1779910001583,"version":"3.53.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T00:00:00Z","timestamp":1715731200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.neurot.2024.e00377","type":"journal-article","created":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T05:35:00Z","timestamp":1716356100000},"page":"e00377","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["A synthetic peptide exerts nontolerance-forming antihyperalgesic and antidepressant effects in mice"],"prefix":"10.1016","volume":"21","author":[{"given":"Yongjiang","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YanZhe","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3669-5687","authenticated-orcid":false,"given":"Gang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1843-753X","authenticated-orcid":false,"given":"Long","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurot.2024.e00377_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(15)60805-4","article-title":"Prevalence of chronic pain in low-income and middle-income countries: a systematic review and meta-analysis","volume":"385","author":"Jackson","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.neurot.2024.e00377_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107581","article-title":"Chemokines in chronic pain: cellular and molecular mechanisms and therapeutic potential","volume":"212","author":"Jiang","year":"2020","journal-title":"Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00377_bib3","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1152\/physrev.00040.2019","article-title":"Cellular circuits in the brain and their modulation in acute and chronic pain","volume":"101","author":"Kuner","year":"2021","journal-title":"Physiol Rev"},{"key":"10.1016\/j.neurot.2024.e00377_bib4","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev-pharmtox-010818-021524","article-title":"Neuropathic pain: mechanism-based therapeutics","volume":"60","author":"Bannister","year":"2020","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"6424","key":"10.1016\/j.neurot.2024.e00377_bib5","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1126\/science.aap8586","article-title":"An amygdalar neural ensemble that encodes the unpleasantness of pain","volume":"363","author":"Corder","year":"2019","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.neurot.2024.e00377_bib6","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1038\/s41593-019-0468-2","article-title":"A\u00a0neural circuit for comorbid depressive symptoms in chronic pain","volume":"22","author":"Zhou","year":"2019","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.neurot.2024.e00377_bib7","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.coph.2021.02.007","article-title":"Opportunities and challenges for nonaddictive interventions in chronic pain","volume":"57","author":"Malafoglia","year":"2021","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.neurot.2024.e00377_bib8","first-page":"589","article-title":"Toward a systematic approach to opioid rotation","volume":"7","author":"Smith","year":"2014","journal-title":"J\u00a0Pain Res"},{"issue":"5","key":"10.1016\/j.neurot.2024.e00377_bib9","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0301-0082(02)00008-4","article-title":"Exploring the opioid system by gene knockout","volume":"66","author":"Kieffer","year":"2002","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.neurot.2024.e00377_bib10","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev-med-011817-044739","article-title":"Use and misuse of opioids in chronic pain","volume":"69","author":"Volkow","year":"2018","journal-title":"Annu Rev Med"},{"issue":"4","key":"10.1016\/j.neurot.2024.e00377_bib11","doi-asserted-by":"crossref","first-page":"500","DOI":"10.2105\/AJPH.2017.304265","article-title":"Quantifying the epidemic of prescription opioid overdose deaths","volume":"108","author":"Seth","year":"2018","journal-title":"Am J Publ Health"},{"issue":"3","key":"10.1016\/j.neurot.2024.e00377_bib12","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1124\/jpet.103.055590","volume":"307","author":"Petrillo","year":"2003","journal-title":"J\u00a0Pharmacol Exp Therapeut"},{"issue":"3","key":"10.1016\/j.neurot.2024.e00377_bib13","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.pain.2007.07.010","article-title":"Inflammation-induced changes in rostral ventromedial medulla mu and kappa opioid receptor mediated antinociception","volume":"136","author":"Schepers","year":"2008","journal-title":"Pain"},{"issue":"14","key":"10.1016\/j.neurot.2024.e00377_bib14","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1111\/bph.13809","article-title":"Targeting multiple opioid receptors-improved analgesics with reduced side effects?","volume":"175","author":"Gunther","year":"2018","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neurot.2024.e00377_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109045","article-title":"PPL-138 (BU10038): a bifunctional NOP\/mu partial agonist that reduces cocaine self-administration in rats","volume":"211","author":"Cippitelli","year":"2022","journal-title":"Neuropharmacology"},{"issue":"31","key":"10.1016\/j.neurot.2024.e00377_bib16","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2204114119","article-title":"An analgesic peptide H-20 attenuates chronic pain via the PD-1 pathway with few adverse effects","volume":"119","author":"Zhao","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"issue":"18","key":"10.1016\/j.neurot.2024.e00377_bib17","doi-asserted-by":"crossref","first-page":"13394","DOI":"10.1021\/acs.jmedchem.1c00694","article-title":"Development of multifunctional and orally active cyclic peptide agonists of opioid\/neuropeptide FF receptors that produce potent, long-lasting, and peripherally restricted antinociception with diminished side effects","volume":"64","author":"Zhang","year":"2021","journal-title":"J\u00a0Med Chem"},{"issue":"12","key":"10.1016\/j.neurot.2024.e00377_bib18","first-page":"1526","article-title":"Novel endomorphin analogs are more potent and longer-lasting analgesics in neuropathic, inflammatory, postoperative, and visceral pain relative to morphine","volume":"18","author":"Feehan","year":"2017","journal-title":"J\u00a0Pain"},{"issue":"7","key":"10.1016\/j.neurot.2024.e00377_bib19","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nn.4571","article-title":"PD-L1 inhibits acute and chronic pain by suppressing nociceptive neuron activity via PD-1","volume":"20","author":"Chen","year":"2017","journal-title":"Nat Neurosci"},{"issue":"9","key":"10.1016\/j.neurot.2024.e00377_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115438","article-title":"Design, synthesis, and biological activity of new endomorphin analogs with multi-site modifications","volume":"28","author":"Zhao","year":"2020","journal-title":"Bioorg Med Chem"},{"issue":"3-4","key":"10.1016\/j.neurot.2024.e00377_bib21","first-page":"477","article-title":"Spinal DN-9, a peptidic\u00a0multifunctional opioid\/neuropeptide FF agonist produced potent nontolerance forming analgesia with limited side effects","volume":"21","author":"Wang","year":"2020","journal-title":"J\u00a0Pain"},{"issue":"8","key":"10.1016\/j.neurot.2024.e00377_bib22","first-page":"CD006146","article-title":"Opioids for neuropathic pain","volume":"2013","author":"McNicol","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.neurot.2024.e00377_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109437","article-title":"The salt-inducible kinases inhibitor HG-9-91-01 exhibits antidepressant-like actions in mice exposed to chronic unpredictable mild stress","volume":"227","author":"Huang","year":"2023","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00377_bib24","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41398-022-02192-6","article-title":"A\u00a0key role of miR-132-5p in the prefrontal cortex for persistent prophylactic actions of (R)-ketamine in mice","volume":"12","author":"Ma","year":"2022","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.neurot.2024.e00377_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.105011","article-title":"Crosstalk between mu-opioid receptors and neuroinflammation: consequences for drug addiction and pain","volume":"145","author":"Cuitavi","year":"2023","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.neurot.2024.e00377_bib26","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.pharmthera.2019.04.009","article-title":"Targeting opioid dysregulation in depression for the development of novel therapeutics","volume":"201","author":"Browne","year":"2019","journal-title":"Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.neurot.2024.e00377_bib27","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41583-018-0028-x","article-title":"Opioid receptors: drivers to addiction?","volume":"19","author":"Darcq","year":"2018","journal-title":"Nat Rev Neurosci"},{"issue":"456","key":"10.1016\/j.neurot.2024.e00377_bib28","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aar3483","article-title":"A\u00a0bifunctional nociceptin and mu-opioid receptor agonist is analgesic without opioid side effects in nonhuman primates","volume":"10","author":"Ding","year":"2018","journal-title":"Sci Transl Med"},{"issue":"9","key":"10.1016\/j.neurot.2024.e00377_bib29","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1021\/acschemneuro.0c00086","article-title":"Design, synthesis, and characterization of the macrocyclic tetrapeptide cyclo[Pro-Sar-Phe-d-Phe]: a mixed opioid receptor agonist-antagonist following oral administration","volume":"11","author":"Ferracane","year":"2020","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.neurot.2024.e00377_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107690","article-title":"Targeting MOR-mGluR(5) heteromers reduces bone cancer pain by activating MOR and inhibiting mGluR5","volume":"160","author":"Shueb","year":"2019","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00377_bib31","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/j.pain.0000000000000363","article-title":"A\u00a0randomized, phase 2 study investigating TRV130, a biased ligand of the mu-opioid receptor, for the intravenous treatment of acute pain","volume":"157","author":"Viscusi","year":"2016","journal-title":"Pain"},{"issue":"21","key":"10.1016\/j.neurot.2024.e00377_bib32","doi-asserted-by":"crossref","first-page":"11820","DOI":"10.1073\/pnas.2000712117","article-title":"Biased signaling by endogenous opioid peptides","volume":"117","author":"Gomes","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neurot.2024.e00377_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108673","article-title":"A\u00a0promising chemical series of positive allosteric modulators of the mu-opioid receptor that enhance the antinociceptive efficacy of opioids but not their adverse effects","volume":"195","author":"Pryce","year":"2021","journal-title":"Neuropharmacology"},{"issue":"16","key":"10.1016\/j.neurot.2024.e00377_bib34","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2000017118","article-title":"Positive allosteric modulation of the mu-opioid receptor produces analgesia with reduced side effects","volume":"118","author":"Kandasamy","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neurot.2024.e00377_bib35","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.neuropharm.2017.02.020","article-title":"Effects of paclitaxel on the development of neuropathy and affective behaviors in the mouse","volume":"117","author":"Toma","year":"2017","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.neurot.2024.e00377_bib36","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jse.2012.04.001","article-title":"Is shoulder pain for three months or longer correlated with depression, anxiety, and sleep disturbance?","volume":"22","author":"Cho","year":"2013","journal-title":"J\u00a0Shoulder Elbow Surg"},{"issue":"16","key":"10.1016\/j.neurot.2024.e00377_bib37","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1017\/S0033291717001477","article-title":"Depression and pain: primary data and meta-analysis among 237952 people across 47 low- and middle-income countries","volume":"47","author":"Stubbs","year":"2017","journal-title":"Psychol Med"},{"key":"10.1016\/j.neurot.2024.e00377_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2023.171004","article-title":"Endogenous opiates and behavior: 2021","volume":"164","author":"Bodnar","year":"2023","journal-title":"Peptides"},{"key":"10.1016\/j.neurot.2024.e00377_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104800","article-title":"The opioid system in depression","volume":"140","author":"Jelen","year":"2022","journal-title":"Neurosci Biobehav Rev"},{"issue":"14","key":"10.1016\/j.neurot.2024.e00377_bib40","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.2174\/138161209788168100","article-title":"Opiates as antidepressants","volume":"15","author":"Berrocoso","year":"2009","journal-title":"Curr Pharmaceut Des"},{"issue":"4","key":"10.1016\/j.neurot.2024.e00377_bib41","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2174\/1570159043359477","article-title":"Buprenorphine: a unique drug with complex pharmacology","volume":"2","author":"Lutfy","year":"2004","journal-title":"Curr Neuropharmacol"},{"issue":"10","key":"10.1016\/j.neurot.2024.e00377_bib42","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/syn.21914","article-title":"Mediation of buprenorphine analgesia by a combination of traditional and truncated mu opioid receptor splice variants","volume":"70","author":"Grinnell","year":"2016","journal-title":"Synapse"},{"issue":"3","key":"10.1016\/j.neurot.2024.e00377_bib43","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.neulet.2005.02.026","article-title":"Evidence for the involvement of the opioid system in the agmatine antidepressant-like effect in the forced swimming test","volume":"381","author":"Zomkowski","year":"2005","journal-title":"Neurosci Lett"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00377_bib44","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1017\/S1461145711001842","article-title":"Active behaviours produced by antidepressants and opioids in the mouse tail suspension test","volume":"16","author":"Berrocoso","year":"2013","journal-title":"Int J Neuropsychopharmacol"},{"issue":"12","key":"10.1016\/j.neurot.2024.e00377_bib45","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.biopsych.2022.05.030","article-title":"Contribution of the opioid system to the antidepressant effects of fluoxetine","volume":"92","author":"Carazo-Arias","year":"2022","journal-title":"Biol Psychiatr"},{"issue":"36","key":"10.1016\/j.neurot.2024.e00377_bib46","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abb9414","article-title":"Parabrachial neuron types categorically encode thermoregulation variables during heat defense","volume":"6","author":"Yang","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.neurot.2024.e00377_bib47","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1146\/annurev.pa.28.040188.002241","article-title":"The opioid system and temperature regulation","volume":"28","author":"Adler","year":"1988","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.neurot.2024.e00377_bib48","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.brainres.2009.06.039","article-title":"Role of preoptic opioid receptors in the body temperature reduction during hypoxia","volume":"1286","author":"Scarpellini","year":"2009","journal-title":"Brain Res"},{"issue":"24","key":"10.1016\/j.neurot.2024.e00377_bib49","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1016\/j.cub.2019.10.027","article-title":"Activation of kappa opioid receptor regulates the hypothermic response to calorie restriction and limits body weight loss","volume":"29","author":"Cintron-Colon","year":"2019","journal-title":"Curr Biol"},{"key":"10.1016\/j.neurot.2024.e00377_bib50","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.80139","article-title":"TRPV1 drugs alter core body temperature via central projections of primary afferent sensory neurons","volume":"11","author":"Yue","year":"2022","journal-title":"Elife"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747924000631?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747924000631?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T01:11:33Z","timestamp":1727140293000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747924000631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1878747924000631"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2024.e00377","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A synthetic peptide exerts nontolerance-forming antihyperalgesic and antidepressant effects in mice","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2024.e00377","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00377"}}